Genetic Testing Decision Aid

Part of paid clinical trials in Boston, Massachusetts.

Sponsor
Massachusetts General Hospital
Study ID
NCT05470920
Status
Recruiting

Conditions

  • Epithelial Ovarian Carcinoma
  • Pancreas Adenocarcinoma

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Electronic Decision Aid — BEHAVIORAL
    Decision aid followed by an appointment with an oncologist. Will complete surveys/questionnaires
  • Pre-Test Genetic Counseling — BEHAVIORAL
    Receive pretest counseling with a genetic counselor. Will complete surveys/questionnaires

Study Details

This is a randomized trial to evaluate the effectiveness of an electronic decision aid tool versus a traditional genetic counselor session for multi-gene panel testing for people with ovarian or pancreatic cancer

Key Dates

Start date
Oct 14, 2022
Status verified
Aug 2025
Primary completion
Sep 30, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
350 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Experimental: Electronic decision aid arm
    Receive decision aid followed by an appointment with their oncologist.
  • Active Comparator: Genetic counselor Arm
    Receive pretest counseling with a genetic counselor.

Primary Outcome Measure

Average change in knowledge survey score [ Time Frame: baseline (prior to participant completing either genetics sessions) to 1-week following session, approximately 2 weeks ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Massachusetts General HospitalBostonMassachusetts02115
Daniel C. Chung, MD
(617) 726-8687
Daniel C. Chung, MD (PRINCIPAL_INVESTIGATOR)
Mass General at North Shore Cancer CenterDanversMassachusetts01923
Sara Bouberhan, MD
Sara Bouberhan, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Boston, MA

Related Studies